Armata Pharmaceuticals, Inc. — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2020-02-12

Reporting Person: Schlesinger Sarah J. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-12	Stock Option (Right to Buy)	$4.17	A	27383	Acquired	2030-02-12	Common Stock (27383)	Direct

Footnotes

F1: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each annual anniversary of the date of grant.